1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Spain Pharmaceuticals and Healthcare Report Q1 2016

Spain Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 83 pages

Includes 3 FREE quarterly updates

BMI View: We maintain our subdued outlook for the Spanish pharmaceutical market Price caps onoriginator medicines have negatively impacted the country's generic drug sector, which lags behind otherEuropean markets However, new measures to improve access to generic and biosimilar medicines will leadto greater opportunities for generic drugmakers operating in the country

Headline Expenditure Projections

- Pharmaceuticals: EUR2471bn (USD3311bn) in 2014 to EUR2518bn (USD2770bn) in 2015;+19% in local currency terms and -163% in US dollar terms Forecast unchanged from last quarter

- Healthcare: EUR9072bn (USD12156bn) in 2014 to EUR9169bn (USD10086bn) in 2015; +11% inlocal currency terms and -170% in US dollar terms Forecast in line with last quarter

Table Of Contents

Spain Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Spain 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Spain 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Spain 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Spain 2013-2019) 28
Pharmaceuticals and Healthcare Risk/Reward Index 29
Western Europe Risk/Reward Index 29
Spain Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 38
Parallel Trade 39
OTC Medicines 40
Generic Medicines 41
Pricing Regime 41
Reference Pricing System 43
Reimbursement Regime 46
Market Overview 47
Epidemiology 48
Healthcare Sector 50
Table: Regional Public Hospital Debt - Values In EURmn 51
Table: Healthcare Resources (Spain 2009-2014) 53
Table: Healthcare Personnel (Spain 2009-2014) 53
Table: Healthcare Activity (Spain 2009-2014) 54
Research and Development 54
Clinical Trials 55
Competitive Landscape 58
Pharmaceutical Sector 58
Generic Drug Sector 59
Table: Multinational Market Activity 60
Biotechnology Sector 61
Pharmaceutical Retail 63
Company Profile 66
Almirall 66
Esteve 69
Demographic Forecast 72
Demographic Outlook 72
Table: Population Headline Indicators (Spain 1990-2025) 73
Table: Key Population Ratios (Spain 1990-2025) 73
Table: Urban/Rural Population and Life Expectancy (Spain 1990-2025) 74
Table: Population By Age Group (Spain 1990-2025) 74
Table: Population By Age Group % (Spain 1990-2025) 75
Glossary 77
Methodology 79
Pharmaceutical Expenditure Forecast Model 79
Healthcare Expenditure Forecast Model 79
Notes On Methodology 80
Risk/Reward Index Methodology 81
Index Overview 82
Table: Pharmaceutical Risk/Reward Index Indicators 82
Indicator Weightings 83

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.